estrogen receptor 1 |
AZTREONAM |
Estrogen ERalpha |
-20% |
NoneNone |
NoneNone |
View
|
estrogen receptor 1 |
AZTREONAM |
Estrogen ERalpha |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
PHENACETIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
PHENACETIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PHENACETIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
SALICYLIC ACID |
Chemokine CCR5 |
-20% |
NoneNone |
NoneNone |
View
|
dopamine receptor D4 |
CANDESARTAN |
Dopamine D4.2 |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
BENZETHONIUM CHLORIDE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
BENZETHONIUM CHLORIDE |
Adenosine A2A |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
BENZETHONIUM CHLORIDE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
BENZETHONIUM CHLORIDE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
BENZETHONIUM CHLORIDE |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
BENZETHONIUM CHLORIDE |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
BENZETHONIUM CHLORIDE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
BENZETHONIUM CHLORIDE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
MELPHALAN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
MELPHALAN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
matrix metallopeptidase 9 |
PANTOPRAZOLE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
PANTOPRAZOLE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
SALSALATE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
SALSALATE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
SALSALATE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
NAPROXEN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha |
NAPROXEN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, alpha |
NAPROXEN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
NAPROXEN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
NAPROXEN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
NAPROXEN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
NAPROXEN |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, alpha |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
NEOSTIGMINE BROMIDE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
NEOSTIGMINE BROMIDE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
NIMODIPINE |
Phosphodiesterase PDE5 |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
NIMODIPINE |
Phosphodiesterase PDE5 |
-20% |
NoneNone |
NoneNone |
View
|
tachykinin receptor 1 |
NEOSTIGMINE BROMIDE |
Tachykinin NK1 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 1 |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 2 |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
amiloride-sensitive cation channel 5, intestinal |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 gamma |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 beta |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, gamma |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, delta |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type X, alpha |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage gated, type VIII, alpha |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha |
NEOSTIGMINE BROMIDE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, alpha polypeptide |
NANDROLONE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, alpha polypeptide |
NANDROLONE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet derived growth factor receptor, beta polypeptide |
NANDROLONE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, beta polypeptide |
NANDROLONE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
RITONAVIR |
Serotonin 5-HT2C |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
NITRAZEPAM |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
NITRAZEPAM |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
GANCICLOVIR |
Progesterone |
-20% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
GANCICLOVIR |
Progesterone |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
GENTIAN VIOLET |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
GENTIAN VIOLET |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
GENTIAN VIOLET |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
GENTIAN VIOLET |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 5 (DBSS) |
GRANISETRON |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1b |
GRANISETRON |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1a |
GRANISETRON |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 4 |
GRANISETRON |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
GRANISETRON |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 8 |
GRANISETRON |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 5 |
GEMCITABINE |
Glutamate, Kainate |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 4 |
GEMCITABINE |
Glutamate, Kainate |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 3 |
GEMCITABINE |
Glutamate, Kainate |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 2 |
GEMCITABINE |
Glutamate, Kainate |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 1 |
GEMCITABINE |
Glutamate, Kainate |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
GRISEOFULVIN |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
VALPROIC ACID |
HMG-CoA Reductase |
-20% |
NoneNone |
NoneNone |
View
|
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
VALPROIC ACID |
HMG-CoA Reductase |
-20% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
ISOEUGENOL |
Progesterone |
-20% |
NoneNone |
NoneNone |
View
|
progesterone receptor |
ISOEUGENOL |
Progesterone |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
GENISTEIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
GENISTEIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
HYDRALAZINE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
HYDRALAZINE |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
LEVOFLOXACIN |
CYP450-2C19 Inhibition |
-20% |
NoneNone |
NoneNone |
View
|
interleukin 1 receptor, type I |
ISOTRETINOIN |
Interleukin IL-1 alpha |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
ISOTRETINOIN |
Muscarinic M2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
ISOTRETINOIN |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
ISOTRETINOIN |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
GRISEOFULVIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
GRISEOFULVIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
GRISEOFULVIN |
Protein Tyrosine Kinase, Fyn |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 3 |
GLIPIZIDE |
Adrenergic beta3 |
-20% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
MYCOPHENOLIC ACID |
Cannabinoid CB1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
HYDRALAZINE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
HYDRALAZINE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
BROMOCRIPTINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
BROMOCRIPTINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 3 |
ISOTRETINOIN |
Muscarinic M3 |
-20% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
BROMOCRIPTINE |
Neuropeptide Y2 |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase XII |
L-MIMOSINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase VI |
L-MIMOSINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
carbonic anhydrase II |
L-MIMOSINE |
Carbonic Anhydrase |
-20% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
TRANEXAMIC ACID |
Cannabinoid CB1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
TRANEXAMIC ACID |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
TRANEXAMIC ACID |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 2 |
LANSOPRAZOLE |
Adrenergic beta2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
L-MIMOSINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
L-MIMOSINE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
SULINDAC SULFIDE |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
SULINDAC SULFIDE |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
QUINOLONE, CHEMI-LINZ / CYANAMID |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
QUINOLONE, CHEMI-LINZ / CYANAMID |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
matrix metallopeptidase 9 |
LANSOPRAZOLE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
SALSALATE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
SALSALATE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
SALSALATE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
SALSALATE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
SALSALATE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
SALSALATE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
SALSALATE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
SALSALATE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
SALSALATE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
SALSALATE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
SALSALATE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
SALSALATE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
SALSALATE |
GABAA, Chloride Channel, TBOB |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
PROPOFOL |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
PROPOFOL |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
PROPOFOL |
Muscarinic M2 |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 3 |
PROPOFOL |
Muscarinic M3 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
MELPHALAN |
Serotonin 5-HT2B |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
SALSALATE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
SALSALATE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
MELATONIN |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
MELATONIN |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
MELATONIN |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
MELATONIN |
Glycine, Strychnine-Sensitive |
-20% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
MELPHALAN |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
MELPHALAN |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y1 |
PENICILLIN G |
Neuropeptide Y1 |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 4 polypeptide |
SB-203580 |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
SB-203580 |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
SB-203580 |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
SB-203580 |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
SB-203580 |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 3 polypeptide |
SB-203580 |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
SB-203580 |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
SB-203580 |
ATPase, Na+/K+ |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
SB-203580 |
Adrenergic, Norepinephrine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
SALICYLIC ACID |
Adrenergic alpha2B |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 2 |
MODAFINIL |
Adrenergic beta2 |
-20% |
NoneNone |
NoneNone |
View
|
opioid receptor, sigma 1 |
NIMESULIDE |
Sigma1 |
-20% |
NoneNone |
NoneNone |
View
|
platelet-derived growth factor receptor, beta polypeptide |
DOXOFYLLINE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
NIACIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
NIACIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 2 |
SPARFLOXACIN |
Atrial Natriuretic Factor (ANF) |
-20% |
NoneNone |
NoneNone |
View
|
guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) |
SPARFLOXACIN |
Atrial Natriuretic Factor (ANF) |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
STANOZOLOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
LACIDIPINE |
Muscarinic M5 |
-20% |
NoneNone |
NoneNone |
View
|
opioid receptor, sigma 1 |
LACIDIPINE |
Sigma1 |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 5 |
LACIDIPINE |
Chemokine CCR5 |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
LACIDIPINE |
Muscarinic M2 |
-20% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
VALDECOXIB |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
RITONAVIR |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
RITONAVIR |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
RITONAVIR |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
RITONAVIR |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 8 |
SAQUINAVIR |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
SAQUINAVIR |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
SAQUINAVIR |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 3 |
NIFLUMIC ACID |
Muscarinic M3 |
-20% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 5 (DBSS) |
SAQUINAVIR |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|